Related Experiment Video
Updated: Aug 20, 2026

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
Vascular access monitoring improves outcomes
1Fresenius Medical Care, Celebration, FL 34747, USA. Jeffrey.Sands@fmc-na.com
Insights
Regular vascular access monitoring and stenosis correction significantly reduce arteriovenous fistula and graft thrombosis. This proactive approach improves access survival rates for hemodialysis patients.
Area of Science:
- Nephrology
- Vascular Surgery
- Dialysis Access Management
Background:
- Vascular access thrombosis is a major complication in hemodialysis.
- Effective monitoring and intervention strategies are crucial for maintaining access patency.
Purpose of the Study:
- To evaluate the impact of vascular access monitoring and elective stenosis correction on thrombosis rates.
- To assess the long-term efficacy of these interventions in improving access survival.
Main Methods:
- Analysis of existing studies on vascular access monitoring and intervention protocols.
- Comparison of thrombosis rates before and after implementing elective stenosis correction.
- Review of K/DOQI guidelines for access monitoring.
Main Results:
- Vascular access monitoring coupled with elective stenosis correction reduces thrombosis rates by 50-75%.
- Arteriovenous fistula thrombosis rates decrease to 0.1-0.2/patient year.
- Arteriovenous graft thrombosis rates fall below 0.5/patient year.
Conclusions:
- Current data support K/DOQI recommendations for regular access monitoring.
- Access flow measurement, prompt imaging, and elective stenosis correction are recommended for low-flow accesses.
- Despite challenges in long-term impact evaluation, proactive management improves outcomes.
Abstract:
Vascular access monitoring can identify patients at increased risk of future access thrombosis. When coupled with a program of elective stenosis correction, access thrombosis rates decline approximately 50-75%. This results in arteriovenous (AV) fistula thrombosis rates of 0.1-0.2/patient year (vs. 0.2-0.4 at baseline) and AV graft thrombosis rates <0.5/patient year (vs. 0.8-1.2 thromboses/patient year at baseline). Evaluating the long-term impact on access survival remains problematic. There are no large-scale randomized trials and existing studies exhibit marked differences in target populations, clinical protocols and outcome definitions. Differences in payment systems also significantly influence the efficacy of monitoring and intervention programs. Despite these challenges, the current data support the K/DOQI recommendations that all patients undergo a program of regular access monitoring preferably by access flow measurement coupled with prompt imaging and elective stenosis correction for low flow accesses.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management
Aortic Regurgitation IV: Nursing Management